This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Grisendi S, Bernardi R, Rossi M, Cheng K, Khandker L, Manova K et al. Role of nucleophosmin in embryonic development and tumorigenesis. Nature 2005; 437: 147–153.
Borer RA, Lehner CF, Eppenberger HM, Nigg EA . Major nucleolar proteins shuttle between nucleus and cytoplasm. Cell 1989; 56: 379–390.
Falini B, Mason DY . Proteins encoded by genes involved in chromosomal alterations in lymphoma and leukemia: clinical value of their detection by immunocytochemistry. Blood 2002; 99: 409–426.
Raimondi SC, Dube ID, Valentine MB, Mirro Jr J, Watt HJ, Larson RA et al. Clinicopathologic manifestations and breakpoints of the t(3;5) in patients with acute nonlymphocytic leukemia. Leukemia 1989; 3: 42–47.
Yoneda-Kato N, Look AT, Kirstein MN, Valentine MB, Raimondi SC, Cohen KJ et al. The t(3;5)(q25.1;q34) of myelodysplastic syndrome and acute myeloid leukemia produces a novel fusion gene, NPM-MLF1. Oncogene 1996; 12: 265–275.
Hitzler JK, Witte DP, Jenkins NA, Copeland NG, Gilbert DJ, Naeve CW et al. cDNA cloning, expression pattern, and chromosomal localization of Mlf1, murine homologue of a gene involved in myelodysplasia and acute myeloid leukemia. Am J Pathol 1999; 155: 53–59.
Falini B, Mecucci C, Tiacci E, Alcalay M, Rosati R, Pasqualucci L et al. Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype. N Engl J Med 2005; 352: 254–266.
Williams JH, Daly LN, Ingley E, Beaumont JG, Tilbrook PA, Lalonde JP et al. HLS7, a hemopoietic lineage switch gene homologous to the leukemia- inducing gene MLF1. EMBO J 1999; 18: 5559–5566.
Schnittger S, Schoch C, Kern W, Mecucci C, Tschulik C, Martelli MF et al. Nucleophosmin gene mutations are predictors of favourable prognosis in acute myelogenous leukemia with a normal kayotype. Blood, published online August 2 2005.
Winteringham LN, Kobelke S, Williams JH, Ingley E, Klinken SP . Myeloid Leukemia Factor 1 inhibits erythropoietin-induced differentiation, cell cycle exit and p27Kip1 accumulation. Oncogene 2004; 23: 5105–5109.
Hanissian SH, Akbar U, Teng B, Janjetovic Z, Hoffmann A, Hitzler JK et al. cDNA cloning and characterization of a novel gene encoding the MLF1-interacting protein MLF1IP. Oncogene 2004; 23: 3700–3707.
Acknowledgements
This work was supported by the Associazione Italiana per la Ricerca sul Cancro (AIRC) and MURST. Supported in part by NCI Grant CA 76301 and CA 69179 (SWM), NCI Cancer Center CORE grant CA 21765 and by the American Lebanese Syrian Associated Charities (ALSAC), S. Jude Children's Research Hospital. We thank Dr Xiaoli Cui for the expert technical assistance.
Author information
Authors and Affiliations
Corresponding author
Additional information
Supplementary Information accompanies the paper on Leukemia website (http://www.nature.com/leu)
Supplementary information
Rights and permissions
About this article
Cite this article
Falini, B., Bigerna, B., Pucciarini, A. et al. Aberrant subcellular expression of nucleophosmin and NPM-MLF1 fusion protein in acute myeloid leukaemia carrying t(3;5): A comparison with NPMc+ AML. Leukemia 20, 368–371 (2006). https://doi.org/10.1038/sj.leu.2404068
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2404068
This article is cited by
-
Mapping AML heterogeneity - multi-cohort transcriptomic analysis identifies novel clusters and divergent ex-vivo drug responses
Leukemia (2024)
-
NPM1c impedes CTCF functions through cytoplasmic mislocalization in acute myeloid leukemia
Leukemia (2020)
-
Subtype-specific patterns of molecular mutations in acute myeloid leukemia
Leukemia (2017)
-
Myeloid leukemia factor 1 interfered with Bcl-XL to promote apoptosis and its function was regulated by 14-3-3
Journal of Physiology and Biochemistry (2015)
-
p38αMAPK interacts with and inhibits RARα: suppression of the kinase enhances the therapeutic activity of retinoids in acute myeloid leukemia cells
Leukemia (2012)